Sanofi Pharma Day 2021

October 18, 2021 8:00 AM - 6:00 PM

MassBioHub & Virtual, 700 Technology Sq Fl 5 Cambridge MA 02139

Add to Calendar 10/18/2021 8:00:00 AM 10/18/2021 6:00:00 PM Sanofi Pharma Day 2021

Accelerate your emerging company or idea at Sanofi’s 2021 Pharma Days on October 18 & 19.  
 

MassBio’s Pharma Days are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. 

Please note that in-person attendees are required to be fully vaccinated to participate in the event. Additionally, masks will be required in all common areas of the event space except for when eating or drinking; in meeting rooms, attendees can remove masks if they feel comfortable doing so.
 

Engage on October 18 from 8 - 9AM ET | Hear from Sanofi leadership during a fireside chat about how Sanofi is evolving to meet the needs of an ever-changing innovation landscape. This livestreamed session will feature: 

  • John Reed, Executive Vice President, Global Head of Research and Development, Sanofi
  • Alban de La Sablière, Head of Partnering, Sanofi
  • Frank Nestle, Global Head of Research, Sanofi


Discover on October 18 from 3 - 4PM ET | Join Sanofi’s information session for the latest insights on its R&D strategy and therapeutic focus areas in immunology and inflammation (I&I) and cell and gene therapies. This hybrid session will feature:

  • John Bertin, Global Head of the Immunology and Inflammation Research Therapeutic Area, Sanofi
  • Christian Mueller, Global Head of Genomic Medicine Unit, Sanofi


Connect on October 18 & 19 | Meet one-on-one with Sanofi representatives to discuss collaboration opportunities. Sanofi’s specific areas of interest are: 

  • Cell and gene therapies, including gene editing and non-viral delivery technologies 
  • Immunology and inflammation, with a focus on dermatology, respiratory, and gastro-intestinal indications   


Eligibility Guidelines
Sanofi is open to connecting with groundbreaking innovators across all stages of development that have a strong understanding of their technology’s path to product. Sanofi is particularly interested in tangible assets or disruptive technologies.

Protection of intellectual property rights (ex. patents, trademarks, copyright, trade secrets, etc.) of your concept is your responsibility and your responsibility alone. Information you include in your application will be shared with Sanofi representatives. Please note that these representatives did NOT sign Non-Disclosure Agreements (NDAs). Therefore, you should not include any information in your application that you feel could be harmful to your company should that information be disclosed. 

 MassBioHub & Virtual, 700 Technology Sq Fl 5 Cambridge MA 02139
Executive Vice President, Global Head of Research and Development, Sanofi
Dr. Reed, Executive Vice President, serves as the global head of Pharmaceutical Research & Development for Sanofi, reporting to the CEO and participating as a member of the company’s Executive Committee. Prior to joining Sanofi in May 2018, Dr. Reed served as global head of pharmaceutical research and early development at Roche (Basel, Switzerland) for five years (2013-2018). From 2002 to 2013, Dr. Reed served as CEO of Sanford-Burnham Medical Research Institute, La Jolla, California and ran a highly productive laboratory that generated more than 900 research publications, over 130 patents, and that was awarded more than one-hundred research grants and trained over 100 post-doctoral fellows. Dr. Reed served on multiple editorial boards of research journals. He was scientific founder or co-founder of four biotechnology companies. Dr. Reed also served on the Board of Directors for five publicly traded biopharmaceutical and biotechnology companies and on the governing boards for various non-profit biomedical research organizations. During his academic career, Dr. Reed held faculty appointments at several universities. He is a Fellow of the American Association for the Advancement of Science (AAAS) and a recipient of numerous honors and awards for his accomplishments in biomedical research. Dr. Reed obtained his M.D. (medicine) and Ph.D. (immunology) degrees from University of Pennsylvania in 1986 (graduating Alpha Omega Alpha) and his B.A. degree (chemistry) from University of Virginia in 1980 (graduating Phi Kappa Phi). His post-graduate training included residency in Pathology & Laboratory Medicine at the Hospital of the University of Pennsylvania and a post-doctoral fellowship in Molecular Biology at Wistar Institute (Philadelphia).

Brought to you by